These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1282147)

  • 41. Prevalence of hepatitis C virus antibodies in hospital personnel.
    Abb J
    Zentralbl Bakteriol; 1991 Jan; 274(4):543-7. PubMed ID: 1650558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A nested case-control study on association between hepatitis C virus antibodies and primary liver cancer in a cohort of 9,775 men in Taiwan.
    Chang CC; Yu MW; Lu CF; Yang CS; Chen CJ
    J Med Virol; 1994 Jul; 43(3):276-80. PubMed ID: 7523582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Exploration on the association between the pattern of HBV markers and infection of HCV among population].
    Li W; Zhu Y; Hua Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Aug; 15(4):212-4. PubMed ID: 7530602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis.
    Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
    J Hepatol; 1996 Mar; 24(3):271-6. PubMed ID: 8778192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
    Jiang MD
    Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
    Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
    Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
    Poulin C; Courtemanche Y; Serhir B; Alary M
    Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serological investigation on intrafamilial transmission of HCV infection].
    Wang S; Huang Y; Yu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Feb; 15(1):34-7. PubMed ID: 7521795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia.
    Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y
    Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Viral hepatitis among male amphetamine-inhaling abusers.
    Lai SW; Chang WL; Peng CY; Liao KF
    Intern Med J; 2007 Jul; 37(7):472-7. PubMed ID: 17445007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
    Wang SP; Ding H; Zhao OK
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: a community-based study.
    al-Faleh FZ; Ramia S; Arif M; Ayoola EA; al-Rashed RS; al-Jeffry M; Hossain A; el-Hazmi M
    Ann Trop Med Parasitol; 1995 Aug; 89(4):431-7. PubMed ID: 7487230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission.
    Watanabe M; Ohkoshi S; Tawaraya H; Miyajima T; Shimotohno K; Kamimura T; Asakura H
    Transfusion; 1994 Feb; 34(2):125-9. PubMed ID: 7508643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
    Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
    J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients.
    Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG
    Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.